Open AccessMICRONUTRIENT DEFICIENCY IN THE PATHOGENESIS OF INSULIN RESISTANCE AND WAYS TO CORRECT IT
Author(s) -
Myroslava Mykytyuk
Publication year - 2021
Publication title -
problemi endokrinnoï patologìï
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.141
H-Index - 2
eISSN - 2518-1432
pISSN - 2227-4782
DOI - 10.21856/j-pep.2021.4.18
Subject(s) - insulin resistance , micronutrient , micronutrient deficiency , medicine , metabolic syndrome , endocrinology , type 2 diabetes , diabetes mellitus , glycogen synthase , glucose homeostasis , pathogenesis , amylin , polyunsaturated fatty acid , insulin , magnesium deficiency (plants) , biology , chemistry , fatty acid , biochemistry , pathology , magnesium , organic chemistry , islet
The review discusses modern views on the pathogenesis of insulin resistance (IR), in particular the role of micronutrient deficiency. The spread of IR in various somatic pathologies indicates an adaptive IR value not only for glucose homeostasis disorders, but also for metabolism in the body as a whole. A promising area of therapy for IR and cardiovascular diseases closely related to obesity and metabolic syndrome (MS) is the use of modulators of products by the human body of endogenous regulatory factors based on omega-3 polyunsaturated fatty acids. The American Diabetic Association supports adherence to a Mediterranean diet enriched with omega-3 polyunsaturated fatty acids. A meta-analysis of 50 clinical, prospective and cross-examination studies has proven the positive protection effect of the Mediterranean diet on MS components. The development of IR can be associated with a deficiency of chromium and magnesium, and the additional intake of these trace elements with nutritional supplements reduces the severity of IR. Pancreatic β-cell dysfunction, IR, increased risk of MS and type 2 diabetes associated with hypomagnemia. It has been shown that the combination of oral food additives chromium (160 icg/day) and magnesium (200 mg/day) reduces IR more effectively than their use separately, which may be associated with increased induction and repression, respectively, the expression of glucose transporter 4 and glycogen-synthase kinase 3. Thus, micronutrients can be used in complex therapy of patients with IR and associated pathological conditions, such as excess body weight/obesity, type 2 diabetes and MS.